DENTSPLY SIRONA (NASDAQ:XRAY) Given New $38.00 Price Target at Barrington Research

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price lowered by analysts at Barrington Research from $41.00 to $38.00 in a report released on Friday, Benzinga reports. The firm presently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s price target points to a potential upside of 34.32% from the stock’s previous close.

A number of other research firms have also recently commented on XRAY. Robert W. Baird decreased their target price on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a research report on Friday. Needham & Company LLC lowered their target price on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a report on Friday. StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, January 19th. Piper Sandler reaffirmed a “neutral” rating and set a $32.00 price target (down from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday. Finally, SVB Leerink started coverage on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. They set an “outperform” rating and a $42.00 price target on the stock. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $36.90.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY traded down $0.09 during midday trading on Friday, reaching $28.29. The company’s stock had a trading volume of 4,506,594 shares, compared to its average volume of 3,342,785. The stock has a market capitalization of $5.87 billion, a P/E ratio of -45.43, a PEG ratio of 1.22 and a beta of 1.00. DENTSPLY SIRONA has a 12-month low of $26.27 and a 12-month high of $41.65. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. The firm has a 50 day moving average price of $32.24 and a 200-day moving average price of $32.73.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.42. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The company had revenue of $953.00 million for the quarter, compared to analysts’ expectations of $969.45 million. During the same period last year, the firm earned $0.39 earnings per share. DENTSPLY SIRONA’s quarterly revenue was down 2.6% on a year-over-year basis. As a group, equities analysts predict that DENTSPLY SIRONA will post 2.05 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in XRAY. GSA Capital Partners LLP bought a new position in DENTSPLY SIRONA in the 1st quarter worth $655,000. Central Pacific Bank Trust Division purchased a new stake in shares of DENTSPLY SIRONA during the first quarter valued at $64,000. Financial Counselors Inc. boosted its holdings in DENTSPLY SIRONA by 4.2% in the first quarter. Financial Counselors Inc. now owns 218,576 shares of the medical instruments supplier’s stock valued at $7,255,000 after purchasing an additional 8,793 shares during the last quarter. FORA Capital LLC acquired a new position in shares of DENTSPLY SIRONA during the 1st quarter worth about $771,000. Finally, Daiwa Securities Group Inc. raised its holdings in DENTSPLY SIRONA by 7.9% in the 1st quarter. Daiwa Securities Group Inc. now owns 17,652 shares of the medical instruments supplier’s stock valued at $585,000 after acquiring an additional 1,296 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.